Cardiac Complication After Vascular Surgery
CCVS
The Reasons of Repolarization Disturbances Disclosure in Vascular Surgery
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The vascular surgery is a highest risk procedure when considering postoperative complications associated with the cardiovascular system. The leading clinical presentation is acute hemodynamic decompensation. However, one of the possible pathomechanisms might be repolarization disturbances. Many of perioperative risk factors of cardiac complications are modifiable. The identification may help in the global perioperative risk reduction. Aim: The aim of the study was an identification of the factors which may release clinically overt repolarization disturbances. Methods: The study group consisted of 100 patients, diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure. The authors investigated whether age, gender, comorbidities or some perioperative factors (including hemodynamic, metabolic or genetic) were related to the occurrence of clinically concealed repolarization disturbances or clinically disclosed cardiac complications in postoperative time up to 30 day and one year after vascular surgery procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 8, 2017
CompletedFirst Posted
Study publicly available on registry
June 15, 2017
CompletedJune 15, 2017
June 1, 2017
6 years
June 8, 2017
June 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cardiac complications
cardiac complications according to European Society of Cardiology
up to 30 days after vascular procedure
Secondary Outcomes (2)
cardiac complications
during surgical procedure
cardiac complications
one year
Study Arms (1)
vascular surgery patients
* clinically concealed repolarization disturbances during vascular surgery procedure * clinically disclosed cardiac complications during and after vascular surgery procedure
Interventions
* an elective "open" vascular surgery procedure * ECG Holter recording during the procedure and 24 hours after operation (continuous electrocardiographic tracing (digital Holter ECG monitor)
Eligibility Criteria
Adult patients diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure. The study was conducted by the team from Department of Anaesthesiology, Intensive Care and Acute Poisoning of the tertiary teaching hospital at the Pomeranian Medical University in Szczecin, Poland.
You may qualify if:
- adult patients diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure
You may not qualify if:
- heart stimulation,
- atrioventricular and intraventricular conduction defects,
- atrial fibrillation recorded before of the study,
- antiarrhythmic drug treatment (except beta-blockers),
- unoptimal patient general status (uncontrolled diabetes, active infection)
- reoperation
- emergency operations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Metabolic monitoring consisted of electrolytes and arterial blood gas analysis prior to anesthesia induction and at the end of the procedure. Blood was drawn into anticoagulant for genetic studies. Genomic DNA was isolated from peripheral blood leukocytes to investigate rs203462 AKAP10 polymorphism in the study population.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jowita Biernawska, MD, PhD
Department of Anaesthesiology and Intensive Care of the Pomeranian Medical University in Szczecin, Poland.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
June 8, 2017
First Posted
June 15, 2017
Study Start
December 1, 2010
Primary Completion
December 1, 2016
Study Completion
June 1, 2017
Last Updated
June 15, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share